JUST IN: FDA Expected To Authorize 6th mRNA Dose In The Fall
The U.S. Department of Health and Human Services Food and Drug Administration (FDA) is anticipated to authorize a sixth Moderna COVID vaccine dosage meant for COVID-immunocompromised individuals.
The director of the FDA Center for Biologic Evaluation and Research, Peter Marks, said, “I don’t want to shock anyone, but there may be a need for people to get an additional booster in the fall.”
This means that citizens who have been receiving mRNA vaccines could end up taking five or even six COVId vaccinations during this pandemic.
It is unclear if the upcoming mRNA booster will be a variation of current vaccinations meant to target COVID variants.
“It’s not actually clear yet what the optimal booster should be,” Marks explained. “We’re hoping by taking this action, we will help allow people to take steps to protect themselves should we have another wave to come through this country.”
Late last month President Biden received his second booster or fourth shot on live television.
Biden explained that despite the U.S. government having funded billions of dollars for COVID vaccine research and production in the past two years, “if we need a different vaccine for the future to combat a new variant, we are not going to have enough money to purchase it.”
BIDEN: "If we need a different vaccine for the future to combat a new variant, we are not going to have enough money to purchase it." pic.twitter.com/MMxYvrpwHw
— Breaking911 (@Breaking911) March 30, 2022
Biden suggested more taxpayer money could be siphoned to pay for endless more doses made to target “new variants.”
Stay tuned to The Scoop for any updates.